Shalby Ltd

Shalby Ltd has announced the disposal of arbitration proceedings against Dr. Viral Shah and Dr. Praveen Saxena. The orders were issued by the Sole Arbitrator, Hon'ble Justice M. S. Parikh (Retd.), on June 26, 2026, following joint withdrawal/settlement filings by both parties. The company states there is no quantifiable impact on its financial or operational activities, as the matters are fully settled. This development resolves ongoing legal disputes, bringing closure to these arbitration cases.

Shalby Ltd has announced a closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from July 1, 2026, and will reopen 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. All company insiders have been advised against trading in Shalby Ltd's securities during this period.

Shalby Limited issued a clarification regarding a typographical error in its May 27, 2026 Board Meeting announcement. The correct Cost Auditor appointed for the audit of cost accounts for FY 2026-27 is S A & Associates, Ahmedabad (Firm Registration No. 000347), replacing the previously mentioned M/s. Borad Sanjay B & Associates. S A & Associates is a well-established firm specializing in Cost Auditing and Management Consultancy, led by FCMA Sanjay B. Borad, with over two decades of experience across various industries including Metal, FMCG, Chemicals, and Healthcare.

Shalby Ltd's Board of Directors approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The board meeting, which commenced at 5:10 p.m. and concluded at 6:09 p.m., also saw the appointment of M/s. Borad Sanjay B & Associates as the cost accountant for FY 2026-27. The board did not recommend any dividend for the financial year 2025-26. The 22nd Annual General Meeting is scheduled for September 10, 2026.

Shalby Ltd. announced that its step-down subsidiary, Ninegen Lifecare Pvt. Ltd., has been struck off from the Register of Companies by the Ministry of Corporate Affairs, effective May 12, 2026. This action means Ninegen Lifecare is no longer a subsidiary of PK Healthcare Pvt. Ltd and consequently, no longer a step-down subsidiary of Shalby Ltd. The company has confirmed that this strike-off will not have any material financial impact on its business, operations, or financials.

Shalby Ltd has announced that a meeting of the Board of Directors is scheduled for May 27, 2026, to consider and approve the audited financial results (standalone and consolidated) for the quarter and financial year ended March 31, 2026. The board will also consider recommending a dividend on the equity shares for the financial year 2025-26, subject to member approval. The trading window for the company's equity shares has been closed from April 1, 2026, and will remain closed until 48 hours after the financial results are made public.

Shalby Ltd announced the resignation of Mr. Vijay Kishanlal Kedia from the Board of Directors as an Independent Director, effective from the close of business hours on April 30, 2026. Mr. Kedia cited "increasing professional commitments and time constraints" as the reason for his resignation. The Board of Directors placed on record its appreciation for his valuable contribution and guidance during his tenure. Mr. Kedia also holds a directorship as a Non-Executive Director at Atul Auto Ltd.

Shalby Ltd has received an order from the Income Tax Appellate Tribunal (ITAT), Ahmedabad Bench, dated March 16, 2026, disallowing the company's appeal and demanding Rs. 4.14 crore. The demand relates to an issue where Shalby Surat Hospital Pvt. Ltd. (SSHPL), prior to its demerger, issued unquoted shares at a premium based on a valuation report. The Assessing Officer had previously disallowed this premium and added it to income under Section 68. Shalby Ltd received the ITAT order on April 10, 2026. The company states there is no immediate financial implication as it plans to contest the order at appropriate forums, expecting a favorable outcome.

Shalby Ltd announced that its Krishna unit in Ahmedabad, Gujarat, has received approval for kidney transplant services. This approval is valid for a period of five years, effective from April 9, 2026. The company stated that this development will enable patients in the surrounding community to access advanced, life-saving transplant services locally, thereby reducing the need for long-distance travel and associated costs. It also aims to enhance continuity of care by offering comprehensive pre- and post-transplant management under one roof.

Shalby Ltd, a renowned name in the healthcare sector, has issued a Standby Letter of Credit (SBLC) of up to USD 13.27 Million for its step-down subsidiary, Shalby Advanced Technologies, Inc., USA (SAT Inc.). The SBLC has been availed from IndusInd Bank Limited. This move is expected to aid SAT Inc. in obtaining credit facilities. The Company has clarified that this decision is in its overall interest and does not foresee any significant financial or operational impact.